| Fund ID | 805-3136594080 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 93% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Arsenal Capital Partners Vi-B LP | Private Equity | $2.41B |
| Arsenal Capital Partners VI LP | Private Equity | $1.76B |
| Arsenal Capital Partners V LP | Private Equity | $1.65B |
Acp Biospecimen Holdings, LLC reports $6.5 million in gross assets, among the top 82% of private funds by size.
Acp Biospecimen Holdings, LLC is managed by Arsenal Capital Management LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.